Skip to main content
logo
Genflow Biosciences plc (LON:GENF)
London flag London · Delayed Price · Currency is GBP · Price in GBX
2.140
+0.190 (9.74%)
Aug 14, 2026, 4:35 PM GMT

Genflow Biosciences Balance Sheet

Millions GBP. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.110.280.682.360.22
Cash & Short-Term Investments
0.110.280.682.360.22
Cash Growth
-59.88%-59.26%-70.97%951.87%-11.89%
Other Receivables
0.30.040.340.130.02
Receivables
0.30.040.340.130.02
Prepaid Expenses
0.040.070.040.130.03
Total Current Assets
0.450.381.072.620.28
Property, Plant & Equipment
0000-
Total Assets
0.450.391.072.620.28

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.650.370.480.080.04
Accrued Expenses
0.320.070.060.160.17
Current Unearned Revenue
0.020.33---
Other Current Liabilities
0.020.020.030.010.01
Total Current Liabilities
10.790.570.250.22
Total Liabilities
10.790.570.250.22

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.150.10.090.090.07
Additional Paid-In Capital
6.14.834.194.190.63
Retained Earnings
-7.01-5.59-4-2.14-0.81
Comprehensive Income & Other
0.210.250.220.230.16
Shareholders' Equity
-0.55-0.40.52.370.06
Total Liabilities & Equity
0.450.391.072.620.28

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
0.110.280.682.360.22
Net Cash Growth
-59.88%-59.26%-70.97%951.87%-11.89%
Net Cash Per Share
0.000.000.000.010.00
Filing Date Shares Outstanding
493.55349.71292.51292.51292.51
Total Common Shares Outstanding
493.55349.71292.51292.51244.57
Working Capital
-0.55-0.410.52.360.06
Book Value Per Share
-0.00-0.000.000.010.00
Tangible Book Value
-0.55-0.40.52.370.06
Tangible Book Value Per Share
-0.00-0.000.000.010.00